Evidence map›Paper›PMID 27822313›Full record

ArticleEpigenetics & chromatin2016

Quantitative analysis of ChIP-seq data uncovers dynamic and sustained H3K4me3 and H3K27me3 modulation in cancer cells under hypoxia.

Michiel E Adriaens, Peggy Prickaerts, Michelle Chan-Seng-Yue, Twan van den Beucken, Vivian E H Dahlmans, Lars M Eijssen, Timothy Beck, Bradly G Wouters, Jan Willem Voncken, Chris T A Evelo

Open access · goldAbstract read
In one paragraph

Article in Epigenetics & chromatin, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Alterations to the yeast chromatin landscape during hypoxia.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Hypoxic Regulation of Gene Transcription and Chromatin: Cause and Effect.International journal of molecular sciences · 2020
    Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Genetic and epigenetic inactivation ofScience translational medicine · 2017
    Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

Michiel E Adriaens *Maastricht Centre for Systems Biology - MaCSBio, Maastricht University, Maastricht, The Netherlands.ORCID 0000-0002-4472-7119
Peggy Prickaerts *Department of Molecular Genetics, Maastricht University, Maastricht, The Netherlands.
Michelle Chan-Seng-YueDepartments of Informatics and Bio-computing, University Health Network, Toronto, ON Canada.
Twan van den BeuckenPrincess Margaret Cancer Centre and Campbell Family Institute for Cancer Research, University Health Network, Toronto, ON Canada.
Vivian E H DahlmansDepartment of Molecular Genetics, Maastricht University, Maastricht, The Netherlands.
Lars M EijssenDepartment of Bioinformatics - BiGCaT, Maastricht University, Maastricht, The Netherlands.
Timothy BeckDepartments of Informatics and Bio-computing, University Health Network, Toronto, ON Canada.
Bradly G WoutersPrincess Margaret Cancer Centre and Campbell Family Institute for Cancer Research, University Health Network, Toronto, ON Canada.
Jan Willem VonckenDepartment of Molecular Genetics, Maastricht University, Maastricht, The Netherlands.
Chris T A EveloDepartment of Bioinformatics - BiGCaT, Maastricht University, Maastricht, The Netherlands.
Maastricht University · NLUniversity Health Network · CAMaastricht University Medical Centre · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA comprehensive assessment of the epigenetic dynamics in cancer cells is the key to understanding the molecular mechanisms underlying cancer and to improving cancer diagnostics, prognostics and treatment. By combining genome-wide ChIP-seq epigenomics and microarray transcriptomics, we studied the effects of oxygen deprivation and subsequent reoxygenation on histone 3 trimethylation of lysine 4 (H3K4me3) and lysine 27 (H3K27me3) in a breast cancer cell line, serving as a model for abnormal oxygenation in solid tumors. A priori, epigenetic markings and gene expression levels not only are expected to vary greatly between hypoxic and normoxic conditions, but also display a large degree of heterogeneity across the cell population. Where traditionally ChIP-seq data are often treated as dichotomous data, the model and experiment here necessitate a quantitative, data-driven analysis of both datasets.

resultsWe first identified genomic regions with sustained epigenetic markings, which provided a sample-specific reference enabling quantitative ChIP-seq data analysis. Sustained H3K27me3 marking was located around centromeres and intergenic regions, while sustained H3K4me3 marking is associated with genes involved in RNA binding, translation and protein transport and localization. Dynamic marking with both H3K4me3 and H3K27me3 (hypoxia-induced bivalency) was found in CpG-rich regions at loci encoding factors that control developmental processes, congruent with observations in embryonic stem cells.

conclusions

Indexed as

Cell HypoxiaCell Line, TumorChromatin ImmunoprecipitationCpG IslandsCyclin A2EpigenomicsHigh-Throughput Nucleotide SequencingHistonesHumansMCF-7 CellsMethylationOligonucleotide Array Sequence AnalysisSarcoplasmic Reticulum Calcium-Transporting ATPasesSequence Analysis, RNAATP2A3 protein, humanCCNA2 protein, humanCyclin A2HistonesSarcoplasmic Reticulum Calcium-Transporting ATPasesChIP-sequencingData normalizationEpigenomicsH3K27me3H3K4me3HypoxiaMCF7Transcriptomics

Identifiers

PMID27822313
PMCPMC5090954
OpenAlexW2547719815

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.